# Effectiveness of Probiotics to Treat End Stage Renal Disease

> **NCT02929225** · EARLY_PHASE1 · COMPLETED · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 50 (actual)

## Conditions studied

- Kidney Failure, Chronic

## Interventions

- **DRUG:** Bifid Triple Viable Capsules
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT02929225
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2018-01-30
- **Final completion:** 2018-03-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02929225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02929225, "Effectiveness of Probiotics to Treat End Stage Renal Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02929225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*